Making it work: A study of Australian expatriate language and cultural strategies for the workplace in Japan

Australia has maintained a steady and strong business relationship with Japan for over three decades. In fact, Japan ranks first in terms of important export markets for Australia. As a result, it can be assumed that, on a micro-level, the possibility of more expatriates from Australia being stationed in Japan will increase to facilitate business communication and transactions between Australian and Japanese companies. With the creation of multinational workplaces, including Australians and Japanese working together in Japan, comes an increasing necessity for Australian expatriates to have linguistic and cultural competence. While this has been identified in intercultural communication research, the implementations of such findings related to Japanese language proficiency and how it benefits Australian-Japanese workplace communication is seemingly sporadic despite the investment into Japanese language education by Australia

Inositol phosphatase SHIP1 is a primary target of miR-155

MicroRNA-155 (miR-155) has emerged as a critical regulator of immune cell development, function, and disease. However, the mechanistic basis for its impact on the hematopoietic system remains largely unresolved. Because miRNAs function by repressing specific mRNAs through direct 3′UTR interactions, we have searched for targets of miR-155 implicated in the regulation of hematopoiesis. In the present study, we identify Src homology-2 domain-containing inositol 5-phosphatase 1 (SHIP1) as a direct target of miR-155, and, using gain and loss of function approaches, show that miR-155 represses SHIP1 through direct 3′UTR interactions that have been highly conserved throughout evolution. Repression of endogenous SHIP1 by miR-155 occurred following sustained over-expression of miR-155 in hematopoietic cells both in vitro and in vivo, and resulted in increased activation of the kinase Akt during the cellular response to LPS. Furthermore, SHIP1 was also repressed by physiologically regulated miR-155, which was observed in LPS-treated WT versus miR-155−/− primary macrophages. In mice, specific knockdown of SHIP1 in the hematopoietic system following retroviral delivery of a miR-155-formatted siRNA against SHIP1 resulted in a myeloproliferative disorder, with striking similarities to that observed in miR-155-expressing mice. Our study unveils a molecular link between miR-155 and SHIP1 and provides evidence that repression of SHIP1 is an important component of miR-155 biology

New results in rho^0 meson physics

We compare the predictions of a range of existing models based on the Vector Meson Dominance hypothesis with data on e^+ e^- -> pi^+ pi^$ and e^+ e^- -> mu^+ mu^- cross-sections and the phase and near-threshold behavior of the timelike pion form factor, with the aim of determining which (if any) of these models is capable of providing an accurate representation of the full range of experimental data. We find that, of the models considered, only that proposed by Bando et al. is able to consistently account for all information, provided one allows its parameter "a" to vary from the usual value of 2 to 2.4. Our fit with this model gives a point-like coupling (gamma pi^+ \pi^-) of magnitude ~ -e/6, while the common formulation of VMD excludes such a term. The resulting values for the rho mass and pi^+ pi^- and e^+e^- partial widths as well as the branching ratio for the decay omega -> pi^+ pi^- obtained within the context of this model are consistent with previous results.Comment: 34 pages with 7 figures. Published version also available at http://link.springer.de/link/service/journals/10052/tocs/t8002002.ht

Projecting prevalence by stage of care for prostate cancer and estimating future health service needs: protocol for a modelling study

Introduction Current strategies for the management of prostate cancer are inadequate in Australia. We will, in this study, estimate current service needs and project the future needs for prostate cancer patients in Australia. Methods and analysis First, we will project the future prevalence of prostate cancer for 2010-2018 using data for 1972-2008 from the New South Wales (NSW) Central Cancer Registry. These projections, based on modelled incidence and survival estimates, will be estimated using PIAMOD (Prevalence, Incidence, Analysis MODel) software. Then the total prevalence will be decomposed into five stages of care: initial care, continued monitoring, recurrence, last year of life and long-term survivor. Finally, data from the NSW Prostate Cancer Care and Outcomes Study, including data on patterns of treatment and associated quality of life, will be used to estimate the type and amount of services that will be needed by prostate cancer patients in each stage of care. In addition, Central Cancer Registry episode data will be used to estimate transition rates from localised or locally advanced prostate cancer to metastatic disease. Medicare and Pharmaceutical Benefits data, linked with Prostate Cancer Care and Outcomes Study data, will be used to complement the Cancer Registry episode data. The methods developed will be applied Australia-wide to obtain national estimates of the future prevalence of prostate cancer for different stages of clinical care. Ethics and dissemination This study was approved by the NSW Population and Health Services Research Ethics Committee. Results of the study will be disseminated widely to different interest groups and organisations through a report, conference presentations and peer-reviewed articles.This work is supported by the Prostate Cancer Foundation of Australia (grant number: PCFA – YI 0410). Both David Smith and Xue Qin Yu are supported by an Australian NHMRC Training Fellowship (Ref 1016598, 550002). Mark Clements is supported by an Australian NHMRC Career Development Award (Ref 471491)

The Young Cluster Population of M82 Region B

We present observations obtained with the Advanced Camera for Surveys on board the Hubble Space Telescope of the "fossil" starburst region B in the nearby starburst galaxy M82. By comparing UBVI photometry with models, we derive ages and extinctions for 35 U-band selected star clusters. We find that the peak epoch of cluster formation occurred ~ 150 Myr ago, in contrast to earlier work that found a peak formation age of 1.1 Gyr. The difference is most likely due to our inclusion of U-band data, which are essential for accurate age determinations of young cluster populations. We further show that the previously reported turnover in the cluster luminosity function is probably due to the neglect of the effect of extended sources on the detection limit. The much younger cluster ages we derive clarifies the evolution of the M82 starburst. The M82-B age distribution now overlaps with the ages of: the nuclear starburst; clusters formed on the opposite side of the disk; and the last encounter with M81, some 220 Myr ago.Comment: 11 pages, 4 figures, accepted for publication in ApJ Letter

The varying role of the GP in the pathway between colonoscopy and surgery for colorectal cancer: a retrospective cohort study

Extent: 11p.Objectives: To describe general practitioner (GP) involvement in the treatment referral pathway for colorectal cancer (CRC) patients. Design: A retrospective cohort analysis of linked data. Setting: A population-based sample of CRC patients diagnosed from August 2004 to December 2007 in New South Wales, Australia, using the 45 and Up Study, cancer registry diagnosis records, inpatient hospital records and Medicare claims records. Participants: 407 CRC patients who had a colonoscopy followed by surgery. Primary outcome measures: Patterns of GP consultations between colonoscopy and surgery (ie, between diagnosis and treatment). We investigated whether consulting a GP presurgery was associated with time to surgery, postsurgical GP consultations or rectal cancer cases having surgery in a centre with radiotherapy facilities. Results: Of the 407 patients, 43% (n=175) had at least one GP consultation between colonoscopy and surgery. The median time from colonoscopy to surgery was 27 days for those with an intervening GP consultation and 15 days for those without the consultation. 55% (n=223) had a GP consultation up to 30 days postsurgery; it was more common in cases of patients who consulted a GP presurgery than for those who did not (65% and 47%, respectively, adjusted OR 2.71, 95% CI 1.50 to 4.89, p=0.001). Of the 142 rectal cancer cases, 23% (n=33) had their surgery in a centre with radiotherapy facilities, with no difference between those who did and did not consult a GP presurgery (21% and 25% respectively, adjusted OR 0.84, 95% CI 0.27 to 2.63, p=0.76). Conclusions: Consulting a GP between colonoscopy and surgery was associated with a longer interval between diagnosis and treatment, and with further GP consultations postsurgery, but for rectal cancer cases it was not associated with treatment in a centre with radiotherapy facilities. GPs might require a more defined and systematic approach to CRC management.David Goldsbury, Mark Harris, Shane Pascoe, Michael Barton, Ian Olver, Allan Spigelman, Justin Beilby, Craig Veitch, David Weller, Dianne L O'Connel

The PHASES Differential Astrometry Data Archive. I. Measurements and Description

The Palomar High-precision Astrometric Search for Exoplanet Systems (PHASES) monitored 51 sub-arcsecond binary systems to determine precision binary orbits, study the geometries of triple and quadruple star systems, and discover previously unknown faint astrometric companions as small as giant planets. PHASES measurements made with the Palomar Testbed Interferometer (PTI) from 2002 until PTI ceased normal operations in late 2008 are presented. Infrared differential photometry of several PHASES targets were measured with Keck Adaptive Optics and are presented.Comment: 33 pages emulateapj, Accepted to A